European Journal of Rheumatology
Invited Review

Musculoskeletal ultrasound in children: Current state and future directions


University of Pittsburgh, Pittsburgh, PA, USA


Department of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

Eur J Rheumatol 2020; 7: Supplement S28-S37
DOI: 10.5152/eurjrheum.2019.19170
Read: 2311 Downloads: 1358 Published: 31 January 2020

Juvenile idiopathic arthritis (JIA) is a heterogeneous group of chronic inflammatory arthritides that if inadequately treated, may be associated with chronic disability and deformity. Early diagnosis and treatment initiation is essential in the management of patients with JIA. Conventional means of evaluation of disease presence, disease activity and response to therapy including physical exam, labs and x-rays are at times limited and may be insufficient in making an accurate assessment. Musculoskeletal ultrasound (MSUS) is a well-established modality that is patient and family-friendly, non-invasive, does not require sedation and can be performed at the bedside in real-time. MSUS offers information that cannot be attained by standard outcome measures, and may help to advance both diagnosis and treatment of patients with JIA ultimately improving patient outcomes. This review explores the background of MSUS and the current evidence to support its potential role as a diagnostic, disease activity monitoring and interventional tool.

Cite this article as: Brunner E, Ting T, Vega-Fernandez P. Musculoskeletal ultrasound in children: Current state and future directions. Eur J Rheumatol 2020; 7(Suppl 1): S28-S37

EISSN 2148-4279